David J. King

2018

In 2018, David J. King earned a total compensation of $717.3K as Former Chief Scientific Officer at aTYR PHARMA, a 31% increase compared to previous year.

Compensation breakdown

Option Awards$390,000
Salary$304,583
Other$22,729
Total$717,312

King received $390K in option awards, accounting for 54% of the total pay in 2018.

King also received $304.6K in salary and $22.7K in other compensation.

Rankings

In 2018, David J. King's compensation ranked 10,614th out of 14,244 executives tracked by ExecPay. In other words, King earned more than 25.5% of executives.

ClassificationRankingPercentile
All
10,614
out of 14,244
26th
Division
Manufacturing
4,277
out of 5,765
26th
Major group
Chemicals And Allied Products
1,612
out of 2,128
24th
Industry group
Drugs
1,361
out of 1,817
25th
Industry
Biological Products, Except Diagnostic Substances
262
out of 339
23rd
Source: SEC filing on March 28, 2019.

King's colleagues

We found three more compensation records of executives who worked with David J. King at aTYR PHARMA in 2018.

2018

Sanjay Shukla

aTYR PHARMA

Chief Executive Officer

2018

Ashraf Amanullah

aTYR PHARMA

Former Senior Vice President, Biologics, Development and Manufacturing

2018

Jill Broadfoot

aTYR PHARMA

Chief Financial Officer

News

In-depth

You may also like